Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Olaf Heidenreich

Newcastle AuthorsTitleYearFull text
Professor Vasily Grinev
Dr Sirintra Nakjang
Hesta McNeill
Dr Mojgan Reza
Dr Natalia Martinez Soria
et al.
RUNX1/RUNX1T1 mediates alternative splicing and reorganises the transcriptional landscape in leukemia2021
Professor Olaf Heidenreich
Venetoclax and dexamethasone synergize with inotuzumab ozogamicin–induced DNA damage signaling in B-lineage ALL2021
Mankaran Singh
Dr Helen Blair
Philip Berry
Professor Olaf Heidenreich
Multi-drug chemotherapy dose optimisation in preclinical leukaemia models using HPLC-MS/MS2020
Professor Olaf Heidenreich
Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia2019
Dr Helen Blair
Professor Olaf Heidenreich
Subtype-specific regulatory network rewiring in acute myeloid leukemia2019
Dr Deepali Pal
Dr Helen Blair
Professor Olaf Heidenreich
Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemia2019
Dr Paul Sinclair
Dr Helen Blair
Dr Sarra Ryan
Dr Lars Buechler
Joanna Cheng
et al.
Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 212018
Professor Olaf Heidenreich
Professor Hermann Josef Vormoor
Epidemiology and biology of relapse after stem cell transplantation2018
Dr Sarah Fordham
Dr Helen Blair
Dr Claire Elstob
Professor Ruth Plummer
Dr Yvette Drew
et al.
Inhibition of ATR acutely sensitises acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase2018
Patricia Garrido Castro
Professor Olaf Heidenreich
The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis2018
123456789101112131415